Recent major advances in cardiovascular pharmacotherapy
- PMID: 29589064
- DOI: 10.1007/s00228-018-2453-1
Recent major advances in cardiovascular pharmacotherapy
Abstract
The field of cardiovascular pharmacotherapy remains extremely active. The aim of this review is to summarize the recent major advances in cardiovascular pharmacotherapy, with a focus on (1) the new approved drug for treatment of heart failure with reduced ejection fraction-sacubitril/valsartan; (2) proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors; (3) the novel reversal agents for non-vitamin K oral anticoagulants (NOACs); and finally, (4) new evidence on pharmacological treatment of coronary artery disease.
Keywords: Anticoagulation agents; Antidotes; Cardiovascular drugs; Coronary artery disease; Hypercholesterolemia; Systolic heart failure.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Miscellaneous
